Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tove Øyjord"'
Autor:
Maite Emaldi, Esther Rey-Iborra, Ángela Marín, Lorena Mosteiro, David Lecumberri, Tove Øyjord, Noémie Roncier, Gunhild M. Mælandsmo, Javier C. Angulo, Peio Errarte, Gorka Larrinaga, Rafael Pulido, José I. López, Caroline E. Nunes-Xavier
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Immune checkpoint inhibitors in combination with tyrosine kinase inhibitors (TKIs) are improving the response rates of advanced renal cancer patients. However, many treated patients do not respond, making novel immune checkpoint-based immunotherapies
Externí odkaz:
https://doaj.org/article/949a689eebfb4f5cad6f292d3f117000
Autor:
Caroline E. Nunes-Xavier, Maite Emaldi, Janire Mingo, Tove Øyjord, Gunhild M. Mælandsmo, Øystein Fodstad, Peio Errarte, Gorka Larrinaga, Roberto Llarena, José I. López, Rafael Pulido
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Renal cancer cells constitute a paradigm of tumor cells with a glycolytic reprogramming which drives metabolic alterations favouring cell survival and transformation. We studied the expression and activity of pyruvate dehydrogenase kinases (
Externí odkaz:
https://doaj.org/article/3725a04e6a124d489f00f2b0b256bf47
Autor:
Caroline E. Nunes‑Xavier, Maite Emaldi, Janire Mingo, Tove Øyjord, Gunhild M. Mælandsmo, Øystein Fodstad, Peio Errarte, Gorka Larrinaga, Roberto Llarena, José I. López, Rafael Pulido
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/5dabc4b78ce44a08ae82cc15d0f76d15
Autor:
Caroline E. Nunes-Xavier, Christina Tekle, Tove Øyjord, Karine Flem-Karlsen, Vivi Ann Flørenes, Øystein Fodstad, Gunhild Mari Mælandsmo
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
Scientific Reports
Immunoregulatory protein B7-H3 is involved in the oncogenic and metastatic potential of cancer cells, as well as in drug resistance. Resistance to conventional chemotherapy is an important aspect of melanoma treatment, and a better understanding of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91fedcfe45196bf680371574c870118a
http://link.springer.com/article/10.1038/s41598-019-42303-w
http://link.springer.com/article/10.1038/s41598-019-42303-w
Autor:
R. Llarena, José I. López, Øystein Fodstad, R. Pulido, M. Emaldi, Tove Øyjord, Gunhild Mari Mælandsmo, G. Larrinaga, P. Errarte, J.C. Angulo, Caroline E. Nunes-Xavier
Publikováno v:
Annals of Oncology. 32:S1368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d53ae4ad84c69509724eae1bf587df43
https://doi.org/10.1016/j.annonc.2021.08.2072
https://doi.org/10.1016/j.annonc.2021.08.2072
Autor:
Kristine Kleivi Sahlberg, Vesa Hongisto, Christina Tekle, Cathrine Pedersen, Tove Øyjord, Karine Flem Karlsen, Jahn M. Nesland, Ming Tan, Caroline E. Nunes-Xavier, Øystein Fodstad
Publikováno v:
Oncotarget
// Caroline E. Nunes-Xavier 1 , Karine Flem Karlsen 1 , Christina Tekle 1 , Cathrine Pedersen 2 , Tove Oyjord 1 , Vesa Hongisto 3 , Jahn M. Nesland 4 , Ming Tan 5 , Kristine Kleivi Sahlberg 6, 7 , Oystein Fodstad 1, 8 1 Department of Tumor Biology, I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1923a89487d9ad29142d4ee0e76bdb25
https://doi.org/10.18632/oncotarget.6902
https://doi.org/10.18632/oncotarget.6902
Autor:
Vigdis Nygaard, Siver Andreas Moestue, Ingrid J. Bettum, Kotryna Vasiliauskaite, Ellen Tenstad, Solveig Pettersen, Lina Prasmickaite, Tove Øyjord, Gunhild Mari Mælandsmo, Øystein Risa, Anna Barkovskaya, Saurabh Sayajirao Gorad
Publikováno v:
Cancer Letters
Published version available in Cancer Letters. 2015;366(1):71-83. Invasiveness is a hallmark of aggressive cancer like malignant melanoma, and factors involved in acquisition or maintenance of an invasive phenotype are attractive targets for therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e8907076dd49f9c2a8d4178f6672e52
https://doi.org/10.1016/j.canlet.2015.06.006
https://doi.org/10.1016/j.canlet.2015.06.006
Autor:
Silje Nord, Lina Prasmickaite, Siri Juell, Shakila Jabeen, Mads H. Haugen, Gunhild Mari Mælandsmo, Tove Øyjord, Solveig Pettersen, Olav Engebråten, Eivind Valen Egeland, Ellen Tenstad
Publikováno v:
Cancer Research. 78:114-114
Recently the biological and therapeutic perspective on cancer has evolved from focusing on tumor cells only, to include the complex impact of the tumor microenvironment (TME). The TME appears to have a strong influence on both tumor progression and r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::028c3535fae2f450d657e4d9090eddf9
https://doi.org/10.1158/1538-7445.am2018-114
https://doi.org/10.1158/1538-7445.am2018-114
Publikováno v:
Tumor Biology. 28:27-35
We have previously shown that interferon-γ (IFN-γ) inhibits expression of the metastasis-promoting protein S100A4. In the present study, we further explore the mechanism behind the IFN-γ-mediated effects on the human S100A4 promoter and demonstrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ffa4834da3fea3ffb774a85afcdd9ee
https://doi.org/10.1159/000098000
https://doi.org/10.1159/000098000
Autor:
Eivind Valen Egeland, Solveig Pettersen, Kjersti Flatmark, Gunhild Mari Mælandsmo, Kjetil Boye, Tove Øyjord, Mads H. Haugen, Lene Malerød
Publikováno v:
Clinicalexperimental metastasis. 32(8)
S100A4 promotes metastasis in several types of cancer, but the involved molecular mechanisms are still incompletely described. The protein is associated with a wide variety of biological functions and it locates to different subcellular compartments,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7d6bf0112a4adda42e3c103e02eac4
https://pubmed.ncbi.nlm.nih.gov/26349943
https://pubmed.ncbi.nlm.nih.gov/26349943